Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from Cellebrite DI ( (CLBT) ).
Cellebrite reported strong financial results for 2024, achieving a significant 25% growth in annual recurring revenue (ARR) and maintaining a 25% adjusted EBITDA margin, signaling a ‘Rule of 50’ performance. The company experienced a 17% increase in fourth-quarter revenue, driven by a 21% rise in subscription revenue, while also achieving important milestones such as the FedRAMP High Ready designation for its Government Cloud platform. The firm announced leadership changes and strategic advancements, positioning it for sustained growth and profitability in 2025, with expectations of continued top-line expansion and robust free cash flow.
More about Cellebrite DI
Cellebrite DI Ltd. is a global leader in digital investigative solutions serving both the public and private sectors. The company specializes in providing advanced technology solutions to uncover digital evidence for criminal investigations, with a strong market focus on expanding its digital and cloud-based offerings.
YTD Price Performance: 15.05%
Average Trading Volume: 1,523,262
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $5.19B
See more data about CLBT stock on TipRanks’ Stock Analysis page.
